Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Elongin C pseudogene 9 (ELOCP9) is a human gene classified as a pseudogene, meaning it closely resembles a functional gene (Elongin C/ELOC) but does not encode a functional protein. As a pseudogene, ELOCP9 lacks protein-coding potential and has no known biological role, disease associations, or utility as a therapeutic target. ELOCP9 is annotated as a pseudogene, specifically related to the functional Elongin C (ELOC) gene, which is a regulatory subunit involved in transcription elongation and ubiquitin ligase complex assembly. However, ELOCP9 itself does not encode for elongin C protein and is not involved in the molecular pathways or diseases associated with elongin C. ELOCP9 should not be considered a molecular target for therapeutic or mechanistic studies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Elongin C pseudogene 9 (ELOCP9).